Niacinamide, also called nicotinamide, is a form of vitamin B3. It is used in skin creams and serums, and as an oral supplement it has been studied for preventing new skin cancers in people at high risk.
Also known as: nicotinamide, vitamin B3.
Skin products list niacinamide as a percentage. The cream study below used a 5% niacinamide moisturizer, and the skin cancer trials used 500 mg by mouth twice a day. These are study protocols, not a recommendation.
On the skin: in a 12-week split-face study of 50 women aged 40 to 60 (Bissett 2004), a moisturizer with 5% niacinamide improved fine lines and wrinkles, dark spots, texture, red blotchiness and yellowing compared with the same moisturizer without it, and was well tolerated.
By mouth: in a trial of 386 people who had had at least two non-melanoma skin cancers in the past 5 years (Chen 2015), 500 mg of nicotinamide twice a day for 12 months lowered the rate of new non-melanoma skin cancers by 23% compared with placebo, and lowered precancerous actinic keratoses; side effects were similar, and there was no benefit after it was stopped. In a later trial in 158 organ-transplant recipients (Allen 2023), stopped early because of slow recruitment, it did not lower new skin cancers (207 versus 210).
We could not find a published half-life or time to peak for niacinamide that we could cite, so we do not list one.
How Dose Track handles peptides · Reconstitution calculator · Half-life calculator